Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

24,979 signal articles · 242 in last 24h · 119,125 total before filter · latest 1h ago
242last 24h
1542last 7d
260● bullish (7d)
159● bearish (7d)
205publishers
AllMacro297Earnings614M&A105Regulatory21Product14Analyst21
✕ clear all filtersticker: TGTSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
The Bull Case For Target (TGT) Could Change Following Digital Pivot Amid Legal And Product Shifts – Learn Why
Simply Wall St.21d agoneutral
The Bull Case For Target (TGT) Could Change Following Digital Pivot Amid Legal And Product Shifts – Learn Why

In recent weeks, Target Corporation was named as a product seller in a Washington State infant botulism lawsuit linked to recalled Nara Organics Whole Milk Organic Infant Formula, while also adding former 7-Eleven CEO Joe DePinto to its Board and preparing to carry Final Boss Sour products this fall. Alongside these developments, Target has been emphasizing the growth of its interconnected digital ecosystem, spanning same-day services, memberships, advertising, and marketplace offerings,...

87-year-old grocery giant closing more stores
TheStreet21d agoneutral
87-year-old grocery giant closing more stores

As a kid, back in the 1980s, my family did its grocery shopping at the Star Market in our town. That wasn't as much a choice as it was really the only option. There were some specialty markets like butchers and a store that just sold fruit and vegetables, but we didn't have a Target, Walmart, ...

Target (TGT) Faces Formula Lawsuit As Fair Value Stays Just Out Of Reach
Simply Wall St.22d agobearish
Target (TGT) Faces Formula Lawsuit As Fair Value Stays Just Out Of Reach

Target (TGT) is under fresh scrutiny after being named in a lawsuit tied to Nara Organics infant formula that allegedly caused a confirmed case of infant botulism in Washington, which is part of a broader FDA and CDC outbreak investigation. See our latest analysis for Target. The Nara Organics lawsuit lands at a time when Target's share price has a year to date return of 39.63% and a 1 year total shareholder return of 37.63%, while its 5 year total shareholder return is down 36.52%. This...

Target makes another investment in key category it needs to grow
TheStreet26d agoneutral
Target makes another investment in key category it needs to grow

Many of us remember the days when shopping at Target was an experience to look forward to. In recent years, that's changed. Messy aisles, empty shelves, and disorganized inventory have wreaked havoc on the big-box giant's reputation. Now, Target is on a mission to win back shoppers by rebuilding ...

Target (TGT) Stock Could Be 4% Undervalued Despite Boardroom News
Simply Wall St.26d agoneutral
Target (TGT) Stock Could Be 4% Undervalued Despite Boardroom News

Target stock has rebounded in the short term but still carries a 5 year share price decline of about 37.7%. Current valuation checks paint a mixed picture rather than a clear bargain or clear premium. Over the past 5 years, Target shares have declined 37.7%, which keeps longer term holders under water despite more recent gains. Recent news around a potential turnaround in retail execution and boardroom additions can support optimism on future cash flows. However, the ongoing work to rebuild...